Market Tracker

07/29 6:05pm ET

Alkermes Plc (NASDAQ:ALKS)

44.69
Data as of Jul 29
 +0.58 / +1.31%
Today’s Change
29.36
Today|||52-Week Range
54.25
+9.91%
Year-to-Date

Today’s Trading

Previous close44.11
Today’s open44.35
Day’s range44.12 - 45.20
Volume586,333
Average volume (3 months)720,505
Market cap$6.4B
Dividend yield--
Data as of 4:00pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-63.35%
Earnings growth (next 5 years)+21.15%
Revenue growth (last year)+47.59%
P/E ratio372.4
Price/Sales5.42
Price/Book6.19

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-1.13-0.87%
TAROTaro Pharmaceutical ...-0.87-0.61%
PBYIPuma Biotechnology I...+23.99+12.12%
MDVNMedivation Inc-0.10-0.13%
Data as of 4:02pm ET, 07/29/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)$0.14
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane Cooke
Corporate headquarters
Dublin, Dublin

Forecasts